Trademark: 90766720
Word
DEFENCATH (TAUROLIDINE/HEPARIN)
Status Date
Monday, December 18, 2023
Filing Date
Thursday, June 10, 2021
Published for Opposition
Tuesday, April 26, 2022
5 Antimicrobial solution containing both taurolidine and heparin for use as a catheter lock solution
The mark consists of the stylized words "DEFENCATH (TAUROLIDINE/HEPARIN)" with the words "(TAUROLIDINE/HEPARIN)" positioned below the word "DEFENCATH."
"(TAUROLIDINE/HEPARIN)"
Dec 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 18, 2023
Sou Extension 3 Granted
Dec 18, 2023
Sou Extension 3 Filed
Dec 18, 2023
Sou Teas Extension Received
Jun 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 15, 2023
Sou Extension 2 Granted
Jun 15, 2023
Sou Extension 2 Filed
Jun 15, 2023
Sou Teas Extension Received
May 12, 2023
Assigned To Examiner
Dec 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 16, 2022
Sou Extension 1 Granted
Dec 16, 2022
Sou Extension 1 Filed
Dec 16, 2022
Sou Teas Extension Received
Jun 21, 2022
Noa E-Mailed - Sou Required From Applicant
Apr 26, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 26, 2022
Published For Opposition
Apr 6, 2022
Notification Of Notice Of Publication E-Mailed
Mar 23, 2022
Approved For Pub - Principal Register
Mar 23, 2022
Examiner's Amendment Entered
Mar 23, 2022
Notification Of Examiners Amendment E-Mailed
Mar 23, 2022
Examiners Amendment E-Mailed
Mar 23, 2022
Examiners Amendment -Written
Mar 17, 2022
Previous Allowance Count Withdrawn
Mar 15, 2022
Withdrawn From Pub - Og Review Query
Mar 2, 2022
Approved For Pub - Principal Register
Mar 2, 2022
Examiner's Amendment Entered
Mar 2, 2022
Notification Of Examiners Amendment E-Mailed
Mar 2, 2022
Examiners Amendment E-Mailed
Mar 2, 2022
Examiners Amendment -Written
Mar 1, 2022
Assigned To Examiner
Aug 31, 2021
New Application Office Supplied Data Entered
Jun 14, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
